Antithrombotic drugs in secondary stroke prevention: still some way to go

Lancet. 2022 Sep 24;400(10357):974-975. doi: 10.1016/S0140-6736(22)01703-2. Epub 2022 Sep 2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / therapeutic use
  • Brain Ischemia* / drug therapy
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use
  • Secondary Prevention
  • Stroke* / drug therapy

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors